Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0112909 HER2 ANTIGENIC POLYPEPTIDE COMPOSITIONS, AND METHODS FOR THEIR USE IN TREATMENT AND PREVENTION OF CARCINOMAS
Antigenic polypeptides of the growth factor receptor HER2, for breaking the tolerance of a host against self HER2. The antigenic polypeptides include HER2...
2017/0112908 VACCINE
The present invention relates to a vaccine capable to induce the formation of antibodies directed to PCSK9 in vivo.
2017/0112907 NOVEL USES OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS WITH DECREASED DURATION OF EFFECT
This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of...
2017/0112906 STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS
The present invention relates to formulations of ADAMTS13 with enhanced or desirable properties. As such, the invention provides liquid and lyophilized...
2017/0112905 SYSTEMIC GENE REPLACEMENT THERAPY FOR TREATMENT OF X-LINKED MYOTUBULAR MYOPATHY (XLMTM)
The present invention provides compositions and methods for treating a myopathy. In certain embodiments, the invention provides compositions and methods for...
2017/0112904 GLUCAGON RECEPTOR AGONISTS
The present invention relates to compounds with an extended duration of action at the glucagon receptor as compared to native glucagon. Specifically provided...
2017/0112902 REMEDIES FOR AMYOTROPHIC LATERAL SCLEROSIS
The invention presents a therapeutic agent (and progress suppressant) for amyotrophic lateral sclerosis (ALS) containing HGF and/or HGF gene as active...
2017/0112901 LIQUID PHARMACEUTICAL COMPOSITION OF CONJUGATED ERYTHROPOIETIN
A liquid pharmaceutical composition having a conjugated erythropoietin, buffer, sugar, tonicity modifier and amino acid as an aggregation inhibitor. The liquid...
2017/0112900 METHODS FOR PREVENTING OR TREATING CERTAIN DISORDERS BY INHIBITING BINDING OF IL-4 AND/OR IL-13 TO THEIR...
The present disclosure relates to methods of treating, ameliorating or preventing a disorder comprising administering a therapeutically effective amount of a...
2017/0112899 POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF
The present invention provides polypeptide-polymer conjugates. A subject polypeptide-polymer conjugate is useful in a variety of applications, which are also...
2017/0112898 FORMULATIONS OF HEPALATIDE
The present disclosure provides a drug formulation for hepalatide, comprising hepalatide and a buffer salt, and containing or not containing an osmotic...
2017/0112897 METHODS FOR TREATING BRAIN INSULIN RESISTANCE
The invention provides methods for treating brain insulin resistance and/or diseases associated therewith in a subject in need thereof. The methods include...
2017/0112896 SMALL MOLECULE RAC OR RHO INHIBITORS
Disclosed herein are methods of inhibiting Rac or Rho in a cell or tissue or for treating a disease mediated at least in part by Rac or Rho, using a compound...
2017/0112895 PHARMACEUTICAL FORMULATIONS
Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and...
2017/0112894 PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION WITH T CELL ACTIVATING AND/OR CHECKPOINT INHIBITING AGENTS FOR...
This invention provides compounds including peptides and peptidomimetics that can be used to treat cell proliferative disorders, such as those associated with...
2017/0112892 RETINYLAMINE DERIVITIVES FOR TREATMENT OF OCULAR DISORDERS
A pharmaceutical composition includes a retinylamine derivative having the following formula (I): where R.sup.1 is an amino acid residue, a dipeptide or a...
2017/0112891 HINDERED DISULFIDE DRUG CONJUGATES
The invention relates generally to disulfide drug conjugates wherein a linker comprising a sulfur-bearing carbon atom substituted with at least one hydrocarbyl...
2017/0112890 Peptides and Compositions Thereof for Improvement of Glycaemic Management in a Mammal
A peptide having 12 to 60 amino acids and including (a) a sequence of SEQUENCE ID NO: 11, or (b) a fragment of SEQUENCE ID NO: 11 that includes the sequence of...
2017/0112889 POWDER FOR DELIVERY TO THE ORAL CAVITY
A powder for delivery to the oral cavity of a user is disclosed. The powder includes at least two populations of particles. A first population of particles...
2017/0112888 EYE LENS AND METHOD FOR MAKING SAME
An eye lens carrying eyebright extracts includes a matrix and a plurality of extracts dispersed in the matrix, the eyebright being released into the eye over a...
2017/0112887 METHOD FOR THE ATTENUATION OF ATHEROSCLEROSIS CONDITION(S) USING LICORICE EXTRACT AS A MEDICAMENT
The present invention is a method for the attenuation treatment of atherosclerosis condition(s), as manifested by the reduction of the carotid intima-media...
2017/0112886 COMPOSITION CONTAINING ARONIA BERRY EXTRACT, RED SPINACH EXTRACT AND BEETROOT EXTRACT
The present disclosure relates to compositions including a composition comprising red spinach extract, red beet extract, and aronia berry extract that increase...
2017/0112885 HERBAL FORMULATIONS OF CARNIVOROUS PLANTS AND METHODS FOR TREATING INFLAMMATION
Formulations and methods for treating inflammation using pitcher plants. The pitcher plant is made into herbal preparations, such as tinctures and infused...
2017/0112884 ENERGY COMPOSITION
Some embodiments of the invention include administering an energy composition. In some embodiments, administering the energy composition may produce an initial...
2017/0112883 A COMPOSITION FOR USE IN TREATING OR PREVENTING VIRAL OR BACTERIAL INFECTIONS IN A SUBJECT UNDERGOING...
A composition for use as adjunctive therapy to antitumor chemotherapeutic treatments, acquired immunodeficiency syndrome treatments and leukemia treatments is...
2017/0112882 INHIBITING OR REDUCING FUNGAL INFECTIONS
Provided are methods and compositions for inhibiting or reducing fungal growth in or on a subject. The methods comprise exposing the subject to a composition...
2017/0112881 Method of Treating Endometriosis
The present invention is a method of treating or preventing endometriosis by means of administering stem cells to a patient. The stem cells are preferably...
2017/0112880 CARDIAC CELL CULTURE MATERIAL
The purpose of the present invention is to provide a cardiac cell culture material which specifically acts on cardiac cells. In addition, another purpose of...
2017/0112879 METHODS OF PROTECTION AGAINST ISCHEMIA REPERFUSION INJURY
Provided herein are methods of treatment and prevention of ischemia reperfusion (IR) injury comprising administering a mesenchymal stem cell conditioned medium...
2017/0112878 PROGRAMMABLE UNIVERSAL CELL RECEPTORS AND METHOD OF USING THE SAME
The present invention provides programmable universal cell receptors (PUCRs) comprising a catalytic antibody region, a transmembrane domain and a cytoplasmic...
2017/0112877 NON-TOXIC AGENT FOR A BROAD-SPECTRUM, BACTERICIDAL OR BACTERIOSTATIC TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA...
Methods and compositions are provided for a broad-spectrum, bactericidal or bacteriostatic treatment of antibiotic-resistant bacteria in animals with a...
2017/0112876 METHOD OF SELECTING PHOSPHATE BINDER AND ITS USES THEREOF
A method of selecting or determining a candidate compound suitable for use as a phosphate binder is disclosed. The candidate compound includes ferric...
2017/0112875 MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS
A composition for administration to a subject, such as oral administration to a subject, for example, has been provided. Such a composition may comprise at...
2017/0112874 Therapeutic Methods And Pharmaceutical Compositions For Treating Warts With Tellurium Compounds
A novel method for treating skin and mucosal membrane ailments caused by human papilloma viruses, which utilizes tellurium-containing compounds, is disclosed....
2017/0112873 Method and Topical Composition for the Treatment of Rosacea and Skin Erythema Using Selenium Sulfide
A method for the treatment of facial Rosacea and skin erythema using selenium sulfide as the sole active ingredient in a topically applied administration to a...
2017/0112872 METHODS OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections...
2017/0112871 VETERINARY METHODS FOR USING NITRIC OXIDE IN A PLASMA STATE TO TREAT MEDICAL CONDITIONS AND DISEASES IN ANIMALS
Veterinary methods for administering nitric oxide (NO) in a plasma state to a treatment site associated with an animal are disclosed. A discrete stream of...
2017/0112870 ALGIN OLIGOSACCHARIDES AND THE DERIVATIVES THEREOF AS WELL AS THE MANUFACTURE AND THE USE OF THE SAME
The invention provides an alginate oligosaccharide and its derivatives with the degree of polymerization ranging from 2 to 22. The alginate oligosaccharide is...
2017/0112869 COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS
The present disclosure provides compositions, kits, and methods to protect organs by inducing acquired cytoresistance without causing injury to the organ. The...
2017/0112868 2'-Ethynyl Nucleoside Derivatives for Treatment of Viral Infections
The present invention provides a compound of formula A: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein B, Q, R.sup.1, R.sup.5, R.sup.6,...
2017/0112867 PHARMACEUTICAL COMBINATIONS OF SOFOSBUVIR AND RIBAVIRIN
This invention is a novel pharmaceutical composition comprising sofosbuvir and ribavirin and at least one pharmaceutically acceptable excipient for use in the...
2017/0112866 ANTI-TUMOR AGENT CONTAINING TAXANE COMPOUND, AND ANTI-TUMOR EFFECT ENHANCER
In order to provide a novel cancer treatment method using a FTD.cndot.TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side...
2017/0112865 TREATMENT FOR MELANOMA
The present invention relates to combination therapies for melanoma, and in particular, metastatic melanoma. Drugs for use in such combination in include MEK...
2017/0112864 Thyromimetics for the Treatment of Fatty Liver Diseases
The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to...
2017/0112863 NEW COMPOSITION
Compositions and formulations comprising a non-neutralised tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation...
2017/0112862 METHOD FOR TREATING CHRONIC LYMPHOCYTIC LEUKEMIA
The present disclosure provides methods for treating chronic lymphocytic leukemia (CLL) with medicaments useful for same. The medicaments can be pharmaceutical...
2017/0112861 DRUG DELIVERY ENHANCER COMPRISING SUBSTANCE FOR ACTIVATING LYSOPHOSPHOLIPID RECEPTORS
The present invention provides a drug delivery enhancer comprising, as an active ingredient, a substance that activates a lysophospholipid receptor, the...
2017/0112860 NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHODS FOR TREATING BRAIN SWELLING
The present invention is directed to therapeutic compounds, treatment methods, and kits affecting the NC.sub.Ca-ATP channel of neural tissue, including...
2017/0112859 METHOD OF TREATMENT USING AN ASSOCIATION OF LOSARTAN AND ACETYLSALICYLIC ACID, AND KIT
The present invention relates to a method of treatment comprising administering an association of an antihypertensive agent and antiplatelet agent, wherein the...
2017/0112858 Extended Release Aspirin
The present invention is directed to methods of inhibiting platelet aggregation, reducing serum thromboxane B2 levels, reducing systemic or cardiovascular...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.